Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

35.46 +0.20 (+0.57%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer
From Omnicell, Inc.
Via Business Wire
The Analyst Landscape: 5 Takes On Omnicell
Via Benzinga
Omnicell Announces Central Med Automation Service
From Omnicell, Inc.
Via Business Wire
Omnicell to Present at the 2024 Wells Fargo Healthcare Conference
From Omnicell, Inc.
Via Business Wire
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Piper Sandler Upgrades Omnicell: Here's What You Need To Know
Via Benzinga
Crude Oil Moves Lower; Moderna Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Dow Drops Over 500 Points As Data Rolls In
Stocks are paring this morning's gains that followed Meta Platforms' upbeat quarterly results. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
Via Benzinga
Topics Stocks
Exposures US Equities
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
EnlivenHealth® and Good Neighbor Pharmacy® Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution
From Omnicell, Inc.
Via Business Wire
Omnicell Announces Second Quarter 2024 Results
From Omnicell, Inc.
Via Business Wire
3 Russell 2000 Stocks to Buy at a 52-week Low in July
The Russell 2000 is trailing the Nasdaq Composite and S&P500, yet there are still plenty of Russel stocks worth looking into. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024
From Omnicell, Inc.
Via Business Wire
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
From Omnicell, Inc.
Via Business Wire
Omnicell to Present at the BofA Securities 2024 Health Care Conference
From Omnicell, Inc.
Via Business Wire
OMCL Stock Earnings: Omnicell Beats EPS, Beats Revenue for Q1 2024
OMCL stock results show that Omnicell beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Omnicell Announces First Quarter 2024 Results
From Omnicell, Inc.
Via Business Wire
Omnicell Announces XT Amplify
From Omnicell, Inc.
Via Business Wire
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
From Omnicell, Inc.
Via Business Wire
3 Robotics Stocks That Could Soar as the Technology Advances
Discover three robotics stocks set for significant growth as technology evolves. Don't miss out on these opportunities. 
Via InvestorPlace
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
From Omnicell, Inc.
Via Business Wire
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
From Omnicell, Inc.
Via Business Wire
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
From Omnicell, Inc.
Via Business Wire
Omnicell Elects Eileen Voynick to Board of Directors
From Omnicell, Inc.
Via Business Wire
The MACD Indicator: Making Technical Analysis Work
We examine how ordinary investors can use some of Wall Street's best tools like the MACD indicator to beat them at their own game. 
Via InvestorPlace
Omnicell to Present at the Piper Sandler 35th Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
The Relative Strength Index (RSI) Indicator: Does It Work?
The Relative Strength Index (RSI) is a contrarian technical analysis indicator that uses prices to find "overbought" and "oversold" assets. 
Via InvestorPlace
Baptist Health Engages Omnicell in an Effort to Enhance Pharmacy Care and Further Gain Control of Medication Supply Chain
From Omnicell, Inc.
Via Business Wire
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.